Synthetic Genomics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
25 Pages - GLDATA58180
$250.00

Summary

Synthetic Genomics Inc (Synthetic Genomics) is a provider of genomics research, bioproduction, and applied product solutions. The company’s products and services include DNA synthesis services, instrumentation, reagents, and bioinformatics services and software. It provides solutions in genomics research, bioproduction, and applied products. Synthetic Genomics caters its genomics solutions for academic and commercial research and development organizations. It focuses on the production of nutritionals, pharmaceuticals, vaccines, and bio-industrial products derived from renewable biological resources. The company works in partnership with other organizations across multiple industries to provide its products. Synthetic Genomics is headquartered in La Jolla, California, the US.

Synthetic Genomics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Synthetic Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Synthetic Genomics Acquires DNA Technology Patent Portfolio From febit 10
Venture Financing 11
Synthetic Genomics Raises US$10 Million In Venture Financing 11
Partnerships 12
Synthetic Genomics Expands R&D Agreement with Lung Biotech 12
SGI-DNA Enters Into Agreement With Integrated DNA Technologies For Synthetic DNA Products 13
Synthetic Genomics Enters Into Joint Venture Agreement With J. Craig Venter Institute 14
Licensing Agreements 15
Synthetic Genomics Enters Licensing Agreement with Gen9 for Synthetic Biology Technology Patents 15
New England Biolabs Enters Into Licensing Agreement With Synthetic Genomics 16
Equity Offering 17
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 17
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 18
Acquisition 19
Monsanto Invests In Synthetic Genomics, Developer Of Genomic-Driven Solutions 19
Synthetic Genomics Secures An Additional US$35 Million Investment From Life Technologies 20
Synthetic Genomics Inc - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Key Facts 1
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Synthetic Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Synthetic Genomics Inc, Deals By Therapy Area, 2010 to YTD 2016 8
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Synthetic Genomics Acquires DNA Technology Patent Portfolio From febit 10
Synthetic Genomics Raises US$10 Million In Venture Financing 11
Synthetic Genomics Expands R&D Agreement with Lung Biotech 12
SGI-DNA Enters Into Agreement With Integrated DNA Technologies For Synthetic DNA Products 13
Synthetic Genomics Enters Into Joint Venture Agreement With J. Craig Venter Institute 14
Synthetic Genomics Enters Licensing Agreement with Gen9 for Synthetic Biology Technology Patents 15
New England Biolabs Enters Into Licensing Agreement With Synthetic Genomics 16
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 17
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 18
Monsanto Invests In Synthetic Genomics, Developer Of Genomic-Driven Solutions 19
Synthetic Genomics Secures An Additional US$35 Million Investment From Life Technologies 20
Synthetic Genomics Inc, Key Competitors 21
Synthetic Genomics Inc, Key Employees 22
Synthetic Genomics Inc, Subsidiaries 24

List of Figures
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838